Media
07 Nov 2022
JIXING Announces NMPA Acceptance of New Drug Application Submission for Omecamtiv Mecarbil
Read article
26 Aug 2022
JIXING Announces the First Patient Enrolled in China Cohort of Phase 3 Clinical Trial of Aficamten
Read article
22 Jul 2022
JIXING Announces First Patients Enrolled in Phase 3 Clinical Study of OC-01 Nasal Spray in China
Read article
01 Jul 2022
JIXING Announces the First Patient Enrollment in Phase 3 Study of Etripamil in China
Read article